Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis.

[1]  S. Sasayama,et al.  Intracardiac thrombus in murine coxsackievirus B3 myocarditis , 2005, Heart and Vessels.

[2]  O. Kemmotsu,et al.  Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients. , 2003, Thrombosis research.

[3]  B. Xiao,et al.  Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac thrombotic diseases. , 2002, Thrombosis research.

[4]  G. Lip,et al.  Is the Hypercoagulable State in Atrial Fibrillation Mediated by Vascular Endothelial Growth Factor? , 2002, Stroke.

[5]  M. Feldmann,et al.  T cell‐mediated signaling to vascular endothelium: induction of cytokines, chemokines, and tissue factor , 2002, Journal of leukocyte biology.

[6]  G. Lip,et al.  Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study. , 2000, American heart journal.

[7]  S. Mondillo,et al.  Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation. , 2000, International journal of cardiology.

[8]  N. Fiotti,et al.  Coagulation indicators in patients with paroxysmal atrial fibrillation: effects of electric and pharmacologic cardioversion. , 2000, American heart journal.

[9]  M. Topcuoglu,et al.  Plasma levels of coagulation and fibrinolysis markers in acute ischemic stroke patients with lone atrial fibrillation , 2000, Neurological Sciences.

[10]  G. Lip,et al.  A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation. , 2000, Journal of the American College of Cardiology.

[11]  A. Carpi,et al.  Antithrombotic and prothrombotic activities of the vascular endothelium. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  K. Kugiyama,et al.  Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. , 1999, Circulation.

[13]  R. Simari,et al.  Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity. , 1998, Circulation.

[14]  P. Carmeliet,et al.  Molecules in focus Tissue factor , 1998 .

[15]  P. Gallagher,et al.  Atrial Flutter Complicating Neonatal Coxsackie B2 Myocarditis , 1998, Pediatric Cardiology.

[16]  B. Boneu,et al.  Up-regulation of tissue factor expression by platelet-derived growth factor in human vascular smooth muscle cells in culture--role of mitogen-activated protein kinase and effects of intracellular cyclic AMP. , 1997, Thrombosis and haemostasis.

[17]  K. Hatakeyama,et al.  Localization and activity of tissue factor in human aortic atherosclerotic lesions. , 1997, Atherosclerosis.

[18]  M. Russo,et al.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.

[19]  N. Semeraro,et al.  Tissue Factor in Health and Disease , 1997, Thrombosis and Haemostasis.

[20]  K. Berkin,et al.  Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. , 1997, Heart.

[21]  H. Shiku,et al.  Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation , 1996, American journal of hematology.

[22]  S. Amitani,et al.  Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. , 1997, Journal of the American College of Cardiology.

[23]  M. Crawford,et al.  Regional left atrial stasis during fibrillation and flutter determinants and relation to stroke , 1996 .

[24]  A. Frustaci,et al.  Biopsy evidence of atrial myocarditis in an athlete developing transient sinoatrial disease. , 1995, Chest.

[25]  M. Ezekowitz,et al.  Role of transesophageal echocardiography in the detection of left atrial thrombus in patients with chronic nonrheumatic atrial fibrillation. , 1995, American heart journal.

[26]  R. Berg,et al.  Complex atrial tachycardias and respiratory syncytial virus infections in infants. , 1994, The Journal of pediatrics.

[27]  J. Coromilas,et al.  Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study. , 1994, Journal of the American College of Cardiology.

[28]  S. Menahem,et al.  Cardiac arrhythmias as a manifestation of acquired heart disease in association with paediatric respiratory syncitial virus infection , 1993, Journal of paediatrics and child health.

[29]  W. Walsh,et al.  Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. , 1993, American heart journal.

[30]  J. Tijssen,et al.  Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. , 1993, The American journal of cardiology.

[31]  S M Nazarian,et al.  Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1992, The New England journal of medicine.

[32]  M Gent,et al.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. , 1991, Journal of the American College of Cardiology.

[33]  Lippincott Williams Wilkins,et al.  Stroke Prevention in Atrial Fibrillation Study: Final Results , 1991, Circulation.

[34]  N. Mackman,et al.  The Structural Biology of Expression and Function of Tissue Factor , 1991, Thrombosis and Haemostasis.

[35]  Bernard Rosner,et al.  The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. , 1990, The New England journal of medicine.

[36]  Palle Petersen,et al.  PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.

[37]  W. Edwards,et al.  Myocarditis. A histopathologic definition and classification. , 1987, The American journal of cardiovascular pathology.